Cancer Care Ontario, Toronto, ON, Canada
Vicky Simanovski, Noor Ahmad, Leonard Kaizer, Erin Redwood, Kathy Vu, Colleen Fox, Elaine Meertens, Monika K. Krzyzanowska
Background: Oral chemotherapy delivery is complex, making safe medication practices a high priority. Cancer Care Ontario, the provincial government agency responsible for continually improving cancer services in Ontario, undertook a jurisdiction-wide quality improvement initiative to ensure that all oral chemotherapy drugs are prescribed using Computerized Prescriber Order Entry (CPOE) or standardized Pre-printed Orders (PPO). The initiative was further enabled by changes to the provincial funding approach that flows facility funding for oral chemotherapy delivery. Methods: All 35 facilities prescribing chemotherapy in Ontario across 14 regions implemented strategies to work towards the common aim of reducing handwritten/verbal oral chemotherapy prescribing to zero by June 30th, 2015. Baseline audits were completed between Sept-Nov 2014; repeat audits were performed between Mar-May 2015. Each facility reported the number of patients that received an oral chemotherapy prescription, and the method of prescribing. Results: At baseline, 30% of audited prescriptions across the province were handwritten or verbal, which decreased to 9% by June 2015. Improvements were seen in thirteen of the 14 regions. Thirteen out of 35 facilities met the aim of 0 handwritten/verbal orders, with an additional 16 facilities seeing an improvement. Alignment with funding mechanisms, an early physician engagement strategy, and education of key stakeholders on CPOE systems were identified as key enablers to implementation. Conclusions: Though the goal of zero handwritten/verbal prescriptions was not met by all facilities, the initiative encouraged a change in implementing safe prescribing practices for oral chemotherapy. Further audits will assess that the gain was sustained and that the provincial goal is achieved. This initiative is part of a larger strategy to standardize care for systemic treatment patients and promote a culture of safety in hospitals.
Region | % Handwritten/Verbal at Baseline | % Handwritten/Verbal at Year-end | Improvement % |
---|---|---|---|
A | 100 | 14 | 86 |
B | 50 | 0 | 50 |
C | 63 | 30 | 33 |
D | 58 | 27 | 31 |
E | 27 | 8 | 19 |
F | 25 | 7 | 18 |
G | 14 | 0 | 14 |
H | 25 | 9 | 16 |
I | 6 | 0 | 6 |
J | 15 | 10 | 5 |
K | 3 | 0 | 3 |
L | 6 | 5 | 1 |
M | 0 | 0 | 0 |
N | 23 | 20 | 3 |
**Results from two facilities currently outstanding
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2021 ASCO Quality Care Symposium
First Author: Tehsinabanu Sheikh
2023 ASCO Quality Care Symposium
First Author: Marina D. Kaymakcalan
2023 ASCO Quality Care Symposium
First Author: Gury K. Doshi
2022 ASCO Annual Meeting
First Author: Analia Nguyen